These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Is it time to conclude that NMDA antagonists have failed? Roesler R; Quevedo J; Schröder N Lancet Neurol; 2003 Jan; 2(1):13; discussion 13. PubMed ID: 12849294 [No Abstract] [Full Text] [Related]
7. [Modern aspects of investigation and clinical application of glutamatergic agents]. Petrov VI; Onishchenko NV Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079 [TBL] [Abstract][Full Text] [Related]
9. An update of neuroprotectants in clinical development for acute stroke. Lutsep H; Clark W Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Jung KH; Chu K; Lee ST; Park HK; Kim JH; Kang KM; Kim M; Lee SK; Roh JK Biochem Biophys Res Commun; 2009 Jan; 378(3):507-12. PubMed ID: 19056343 [TBL] [Abstract][Full Text] [Related]
14. Memantine as a neuroprotective agent in early phases of psychosis. Fusar-Poli P; Pellegrini F; Cortesi M Med Hypotheses; 2007; 68(2):459-60. PubMed ID: 17005328 [No Abstract] [Full Text] [Related]